Coverart for item
The Resource FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development, Agata Dabrowska

FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development, Agata Dabrowska

Label
FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development
Title
FDA Risk Evaluation and Mitigation Strategies (REMS)
Title remainder
description and effect on generic drug development
Statement of responsibility
Agata Dabrowska
Title variation
Food and Drug Administration Risk Evaluation and Mitigation Strategies (REMS)
Creator
Contributor
Author
Issuing body
Subject
Language
eng
Member of
Is part of
Cataloging source
GPO
Characteristic
updating web site
http://library.link/vocab/creatorName
Dabrowska, Agata
Entry convention
integrated entry
Government publication
federal national government publication
Nature of contents
  • dictionaries
  • bibliography
Nature of entire work
bibliography
Regularity
complete irregular
http://library.link/vocab/relatedWorkOrContributorName
Library of Congress
Series statement
Report / Congressional Research Service
Series volume
R44810
http://library.link/vocab/subjectName
  • United States
  • Generic drugs
  • Pharmaceutical industry
  • Pharmaceutical industry
Label
FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development, Agata Dabrowska
Link
https://purl.fdlp.gov/GPO/gpo114373
Instantiates
Publication
Note
  • The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141
  • Available online
Bibliography note
Report includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
on1080952561
Dimensions
unknown
Edition
Library of Congress public edition.
Extent
1 online resource.
Form of item
online
Lccn
2018253160
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Publication frequency
Updated irregularly
Specific material designation
remote
Label
FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development, Agata Dabrowska
Link
https://purl.fdlp.gov/GPO/gpo114373
Publication
Note
  • The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141
  • Available online
Bibliography note
Report includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
on1080952561
Dimensions
unknown
Edition
Library of Congress public edition.
Extent
1 online resource.
Form of item
online
Lccn
2018253160
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Publication frequency
Updated irregularly
Specific material designation
remote

Library Locations

Library Links

Processing Feedback ...